Autacoids
🟢 Lite — Quick Review (1h–1d)
Autacoids — Key Facts for NEET PG
Histamine:
- H1 receptors: Smooth muscle contraction, vasodilation, pruritus
- H2 receptors: Gastric acid secretion (cimetidine = H2 blocker)
- Antihistamines: Cetirizine, Loratadine (H1); Diphenhydramine (sedating)
Prostaglandins (PGs):
- PGE1, PGE2: Vasodilation, protection, inflammation
- PGF2α: Bronchoconstriction, uterine contraction
- TXA2: Platelet aggregation (aspirin irreversibly inhibits COX → ↓TXA2)
- NSAIDs inhibit COX → ↓PGs (anti-inflammatory, anti-pyretic, analgesic)
Leukotrienes:
- LTC4, LTD4, LTE4 = “Cystinyl leukotrienes” — bronchoconstriction (1000× > histamine)
- Montelukast, Zafirlukast = Leukotriene receptor antagonists
- Zileuton = 5-LOX inhibitor
High-yield point: Aspirin + COX inhibition + TXA2 ↓ → antiplatelet effect (primary prevention vs bleeding risk)
🟡 Standard — Regular Study (2d–2mo)
Autacoids — NEET PG Study Guide
Histamine:
| Receptor | Location | Effect | Blocker |
|---|---|---|---|
| H1 | Smooth muscle, vessels, skin | Pruritus, urticaria, bronchoconstriction | Cetirizine, Loratadine |
| H2 | Gastric parietal cells | ↑ Acid secretion | Cimetidine, Ranitidine, Famotidine |
| H3 | Presynaptic CNS | Autoreceptor (↓ histamine release) | |
| H4 | Eosinophils, mast cells | Chemotaxis |
Anaphylaxis treatment: Adrenaline (IM) → H1 + H2 blockers + steroids
Prostaglandins — Clinical Uses:
- PGE1 (Alprostadil): Patent ductus arteriosus (keeps it open)
- PGE2 (Dinoprostone): Cervical ripening, induction of labour
- Misoprostol (PGE1 analog): NSAID-induced ulcer prophylaxis, medical abortion
- Carboprost (PGF2α analog): Postpartum hemorrhage
Angiotensin:
- ATII: Potent vasoconstriction + aldosterone release
- ACE = Kininase II (breaks down bradykinin)
- ACE inhibitors → ↑ bradykinin → dry cough (common), angioedema (rare)
Platelet-Regulating Autacoids:
| Autacoid | Effect on Platelet | Mechanism |
|---|---|---|
| TXA2 | Aggregation | Via TP receptor |
| PGI2 (Prostacyclin) | Inhibition | Via IP receptor, ↑ cAMP |
| NO | Inhibition | ↑ cGMP |
Serotonin (5-HT):
- 5-HT1A: Anxiolysis, antidepressant (Buspirone)
- 5-HT2A: Vasoconstriction, platelet aggregation (Mirtazapine blocks it → ↑ appetite)
- 5-HT3: Vomiting (Ondansetron = 5-HT3 antagonist)
- 5-HT4: GI motility (Metoclopramide, Cisapride)
🔴 Extended — Deep Study (3mo+)
Autacoids — Comprehensive NEET PG Notes
Detailed Pharmacology:
1. Histamine:
- Source: Mast cells, basophils (preformed + stored)
- Release triggers: IgE-mediated Type 1 hypersensitivity, morphine, codeine, contrast media, muscle relaxants
- Biosynthesis: Histidine → Histamine (histidine decarboxylase)
H1 Antihistamines — Classification:
| Generation | Drug | Sedation | Key Points |
|---|---|---|---|
| 1st | Diphenhydramine, Promethazine | High | Anticholinergic, antiemetic |
| 2nd | Cetirizine, Loratadine | Low | Non-sedating, once daily |
| 3rd | Fexofenadine, Desloratadine | Minimal | Active metabolites |
2. Eicosanoids (Prostaglandins + Leukotrienes):
- Arachidonic acid → via COX → PGs, TXA2
- Arachidonic acid → via LOX → Leukotrienes (LTA4 → LTB4, LTC4-D4-E4)
Leukotriene Pathway:
AA → 5-HPETE → LTA4 → LTB4 (neutrophil chemotaxis)
→ LTC4 → LTD4 → LTE4 (cys-LTs: bronchoconstriction)
- Cys-LT1 antagonists: Montelukast, Zafirlukast
- 5-LOX inhibitor: Zileuton
3. Renin-Angiotensin System:
- Renin cleaves Angiotensinogen → Angiotensin I
- ACE cleaves AT I → AT II
- AT II acts on AT1 receptors → vasoconstriction, aldosterone, ADH, thirst
- ACE inhibitors: Captopril, Enalapril, Ramipril
- ARBs: Losartan, Valsartan
4. Vasoactive Peptides:
| Peptide | Effect | Blocker |
|---|---|---|
| Bradykinin | Vasodilation, pain, ↑ vascular permeability | Icatibant (B2 antagonist) |
| Natriuretic peptides (ANP, BNP) | Natriuresis, vasodilation | Nesiritide (recombinant) |
| Substance P | Pain transmission, NKA > NKB | Aprepitant (NK1 antagonist) |
5. Adenosine:
- Antiplatelet + antiarrhythmic (slows AV conduction)
- Mechanism: A1 receptor → ↓ cAMP
- Clinical: Paroxysmal SVT (IV adenosine)
- Side effect: Bronchospasm (avoid in asthma)
6. Nitric Oxide (NO):
- EDRF from L-arginine (NOS)
- Vasodilator, ↓ platelet aggregation, neurotransmitter
- NO donors: GTN, Sodium nitroprusside
- PDE5 inhibitors (Sildenafil) → ↑ cGMP → enhanced NO effect
Drug Interactions with Autacoids:
- SSRIs + MAOIs + Tyramine → Hypertensive crisis (SSRI + MAOI: serotonin syndrome)
- NSAIDs + ACEi → ↓ renal PGs → ↓ renal blood flow → acute kidney injury
- Aspirin + Warfarin → ↑ bleeding (displacement from albumin)
Clinical Scenarios Frequently Asked in NEET PG:
- Anaphylaxis → IM Adrenaline + IV fluids + H1/H2 blockers + steroids
- Aspirin-exacerbated respiratory disease (AERD) → avoid NSAIDs → leukotriene antagonists
- ACE inhibitor cough → switch to ARB
- Carcinoid syndrome → Octreotide (somatostatin analog)
- Migraine prophylaxis → Propranolol + Flunarizine + Amitriptyline
Content adapted based on your selected roadmap duration. Switch tiers using the selector above.